Wednesday, February 10, 2010, 7:53pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Elite Pharmaceuticals Inc. (ELTP.OB)

At 3:55AM SGT: 0.10 USD   0.00 (0.00%)  
 MORE ON ELTP.OB 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 ELITE PHARMA INC (OTC BB:ELTP.OB) Delayed quote dataEdit
Last Trade:0.10 USD
Trade Time:3:55AM SGT
Change: 0.00 (0.00%)
Prev Close:0.10
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:4.00
Day's Range:N/A - N/A
52wk Range:0.03 - 0.34
Volume:0
Avg Vol (3m):374,686
Market Cap:7.44M
P/E (ttm):N/A
EPS (ttm):-0.10
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add ELTP.OB to Portfolio   Download Data

 HEADLINES 
•ELITE PHARMACEUTICALS INC /DE/ Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statement
EDGAR Online (Sat, Jan 16)
•ELITE PHARMACEUTICALS INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Thu, Dec 3)
•Elite Pharmaceutics and ThePharmaNetwork Announce FDA Approval for Generic Methadone Tablets
GlobeNewswire (Wed, Dec 2)
•ELITE PHARMACEUTICALS INC /DE/ Financials
EDGAR Online Financials (Fri, Nov 20)
•Q2 2009 ELITE PHARMACEUTICALS INC Earnings Release - Time Not Supplied
CCBN (Wed, Nov 18)
•Elite Pharmaceuticals, Inc. to Host Quarterly Conference Call on Wednesday, November 18, 2009
GlobeNewswire (Mon, Nov 16)
•ELITE PHARMACEUTICALS INC /DE/ Files SEC form 10-Q, Quarterly Report
EDGAR Online (Mon, Nov 16)
•ELITE PHARMACEUTICALS INC /DE/ Files SEC form 8-K, Unregistered Sale of Equity Securities, Other Events
EDGAR Online (Fri, Nov 6)
•Elite Pharmaceuticals, Inc. Announces Second Closing of Strategic Alliance Agreement With Epic Pharma
GlobeNewswire (Thu, Nov 5)
•ELITE PHARMACEUTICALS INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Thu, Oct 1)
More Headlines for ELTP.OB...
 ANALYST 
EPS Est (next year) (Mar-10) :N/A
EPS Est (in 2 years) (Mar-11) :N/A
Avg Rec (current)*:2.0
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, manufacture, and license of orally administered controlled release drug delivery systems and products in the United States.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices